» Articles » PMID: 397972

Interrelationships Between Sodium Clearance, Plasma Aldosterone, Plasma Renin Activity, Renal Hemodynamics and Blood Pressure in Renal Disease

Overview
Journal Klin Wochenschr
Specialty General Medicine
Date 1979 Dec 3
PMID 397972
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

This study was designed to evaluate the role of aldosterone, glomerular filtration and blood pressure on sodium excretion in renal disease. Sodium clearance (CNa), plasma aldosterone (PA), plasma renin activity (PRA), glomerular filtration rate (GF), paraaminohippurate clearance (CPAH) and blood pressure were measured simultaneously in 19 normal subjects, 38 patients with benign essential hypertension, 3 with renal artery stenosis, 48 with chronic glomerulonephritis, 20 with the nephrotic syndrome, 24 with tubulo-interstitial disease and 21 with a renal homograft. CNa was significantly depressed in patients with the nephrotic syndrome. Mean PA and PRA were increased in renal artery stenosis but within the normal range in other groups. CNa correlated inversely with PA in all groups but one (tubulo-interstitial disease). CNa correlated directly with GF in the nephrotic syndrome and with the mean blood pressure (mBP) in chronic glomerulonephritis and tubulo-interstitial disease. PA correlated directly with PRA and inversely with GF or CPAH in most groups. It is concluded that PA is an important determinant of the basal natriuresis in renal disease with the exception of tubulo-interstitial nephropathies. In the nephrotic syndrome sodium retention is largely determined by the interaction of PA and GF. In chronic nephropathies, but not in benign essential hypertension, the fractional sodium excretion is partly blood pressure-dependent. Impairment of renal function is often accompanied by a rise in PA.

Citing Articles

Compelling drug indications in diabetic and nondiabetic nephropathy.

Ritz E, Dikow R, Zeier M Curr Hypertens Rep. 2004; 6(4):293-9.

PMID: 15257864 DOI: 10.1007/s11906-004-0024-6.


Hypoaldosteronism without hyperkalemia.

Weidmann P, Gluck Z, Keusch G, REUBI F, de Chatel R, Cottier C Klin Wochenschr. 1980; 58(4):185-94.

PMID: 6991789 DOI: 10.1007/BF01476777.


Renal glycosuria in patients with the nephrotic syndrome.

REUBI F, Seiler A Klin Wochenschr. 1984; 62(13):621-30.

PMID: 6482310 DOI: 10.1007/BF01721917.

References
1.
Bricker N . The control of sodium excretion with normal and reduced nephron populations. The pre-eminence of third factor. Am J Med. 1967; 43(3):313-21. DOI: 10.1016/0002-9343(67)90188-x. View

2.
Davies D, Beevers D, Briggs J, Medina A, Robertson J, SCHALEKAMP M . Abnormal relation between exchangeable sodium and the renin-angiotensin system in malignant hypertension and in hypertension with chronic renal failure. Lancet. 1973; 1(7805):683-6. DOI: 10.1016/s0140-6736(73)91476-1. View

3.
REUBI F, Weidmann P, Hodler J, COTTIER P . Changes in renal function in essential hypertension. Am J Med. 1978; 64(4):556-63. DOI: 10.1016/0002-9343(78)90573-9. View

4.
Davis W, Burwell L, CASPER A, Bartter F . Sites of action of sodium depletion on aldosterone biosynthesis in the dog. J Clin Invest. 1968; 47(6):1425-34. PMC: 297298. DOI: 10.1172/JCI105834. View

5.
Vorburger C, Riedwyl H, REUBI F . [Comparative studies on the renal clearance of Na-Cr2Cr51 ethylenediaminetetraacetate, inulin and sodium thiosulfate in humans]. Klin Wochenschr. 1969; 47(8):415-20. DOI: 10.1007/BF01745785. View